Announcements Trials

Browse Landscape

Status

Completed 1 Available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Lymphoma, T-Cell, Peripheral 1 Lymphoma 1

Interventions

tipifarnib 1 selinexor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Available × Lymphoma, T-Cell, Peripheral × tipifarnib × Clear all

NCT04809233 2025-06-04

Expanded Access to Tipifarnib

Kura Oncology, Inc.

Lymphoma, Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon ⚡